Matches in SemOpenAlex for { <https://semopenalex.org/work/W2900712986> ?p ?o ?g. }
- W2900712986 endingPage "212" @default.
- W2900712986 startingPage "212" @default.
- W2900712986 abstract "Treatment with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) improves the overall survival of patients with EGFR-mutated non-small-cell lung cancer (NSCLC). First-generation EGFR-TKIs (e.g., gefitinib and erlotinib) or second-generation EGFR-TKIs (e.g., afatinib and dacomitinib) are effective for the treatment of EGFR-mutated NSCLC, especially in patients with EGFR exon 19 deletions or an exon 21 L858R mutation. However, almost all cases experience disease recurrence after 1 to 2 years due to acquired resistance. The EGFR T790M mutation in exon 20 is the most frequent alteration associated with the development of acquired resistance. Osimertinib—a third-generation EGFR-TKI—targets the T790M mutation and has demonstrated high efficacy against EGFR-mutated lung cancer. However, the development of acquired resistance to third-generation EGFR-TKI, involving the cysteine residue at codon 797 mutation, has been observed. Other mechanisms of acquired resistance include the activation of alternative pathways or downstream targets and histological transformation (i.e., epithelial–mesenchymal transition or conversion to small-cell lung cancer). Furthermore, the development of primary resistance through overexpression of the hepatocyte growth factor and suppression of Bcl-2-like protein 11 expression may lead to problems. In this report, we review these mechanisms and discuss therapeutic strategies to overcome resistance to EGFR-TKIs." @default.
- W2900712986 created "2018-11-29" @default.
- W2900712986 creator A5008560120 @default.
- W2900712986 creator A5010566372 @default.
- W2900712986 creator A5041182728 @default.
- W2900712986 date "2018-11-15" @default.
- W2900712986 modified "2023-10-13" @default.
- W2900712986 title "Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy" @default.
- W2900712986 cites W1526893002 @default.
- W2900712986 cites W1546552389 @default.
- W2900712986 cites W1566300951 @default.
- W2900712986 cites W1584059175 @default.
- W2900712986 cites W1778149359 @default.
- W2900712986 cites W1840732701 @default.
- W2900712986 cites W1904060183 @default.
- W2900712986 cites W1908940658 @default.
- W2900712986 cites W1921972159 @default.
- W2900712986 cites W1938204876 @default.
- W2900712986 cites W1963677580 @default.
- W2900712986 cites W1964081206 @default.
- W2900712986 cites W1980497534 @default.
- W2900712986 cites W1983774108 @default.
- W2900712986 cites W1986412478 @default.
- W2900712986 cites W1987283660 @default.
- W2900712986 cites W1998038367 @default.
- W2900712986 cites W1998971866 @default.
- W2900712986 cites W2002937040 @default.
- W2900712986 cites W2003984225 @default.
- W2900712986 cites W2006315580 @default.
- W2900712986 cites W2012479646 @default.
- W2900712986 cites W2014230197 @default.
- W2900712986 cites W2033577857 @default.
- W2900712986 cites W2036836102 @default.
- W2900712986 cites W2037873277 @default.
- W2900712986 cites W2043696829 @default.
- W2900712986 cites W2046847797 @default.
- W2900712986 cites W2050369944 @default.
- W2900712986 cites W2057370954 @default.
- W2900712986 cites W2070727232 @default.
- W2900712986 cites W2072120492 @default.
- W2900712986 cites W2074145013 @default.
- W2900712986 cites W2076178766 @default.
- W2900712986 cites W2086468784 @default.
- W2900712986 cites W2088116737 @default.
- W2900712986 cites W2088540000 @default.
- W2900712986 cites W2093613683 @default.
- W2900712986 cites W2095618958 @default.
- W2900712986 cites W2096008575 @default.
- W2900712986 cites W2096198395 @default.
- W2900712986 cites W2096540669 @default.
- W2900712986 cites W2098809458 @default.
- W2900712986 cites W2101329867 @default.
- W2900712986 cites W2103514020 @default.
- W2900712986 cites W2103563973 @default.
- W2900712986 cites W2115269346 @default.
- W2900712986 cites W2115549126 @default.
- W2900712986 cites W2117784514 @default.
- W2900712986 cites W2117986690 @default.
- W2900712986 cites W2119351872 @default.
- W2900712986 cites W2122624068 @default.
- W2900712986 cites W2123027432 @default.
- W2900712986 cites W2126709309 @default.
- W2900712986 cites W2129360604 @default.
- W2900712986 cites W2132157071 @default.
- W2900712986 cites W2132540363 @default.
- W2900712986 cites W2133208325 @default.
- W2900712986 cites W2133488997 @default.
- W2900712986 cites W2133963438 @default.
- W2900712986 cites W2140838553 @default.
- W2900712986 cites W2143913849 @default.
- W2900712986 cites W2146418087 @default.
- W2900712986 cites W2147699387 @default.
- W2900712986 cites W2151981988 @default.
- W2900712986 cites W2154149901 @default.
- W2900712986 cites W2161821474 @default.
- W2900712986 cites W2164618834 @default.
- W2900712986 cites W2166084034 @default.
- W2900712986 cites W2166501552 @default.
- W2900712986 cites W2167934111 @default.
- W2900712986 cites W2171139285 @default.
- W2900712986 cites W2174769990 @default.
- W2900712986 cites W2175694606 @default.
- W2900712986 cites W2207801144 @default.
- W2900712986 cites W2224200645 @default.
- W2900712986 cites W2253835103 @default.
- W2900712986 cites W2256191967 @default.
- W2900712986 cites W2270997383 @default.
- W2900712986 cites W2272802268 @default.
- W2900712986 cites W2292347930 @default.
- W2900712986 cites W2300085745 @default.
- W2900712986 cites W2313212399 @default.
- W2900712986 cites W2336491212 @default.
- W2900712986 cites W2338377057 @default.
- W2900712986 cites W2339311613 @default.
- W2900712986 cites W2400274474 @default.
- W2900712986 cites W2413097448 @default.
- W2900712986 cites W2416111151 @default.
- W2900712986 cites W2465575913 @default.